Clinical Trials
47 trialsNCT06603155 2025-12-19
Time Restricted Eating (TRE) in Metastatic Head and Neck Squamous Cell Cancer (mHNSCC) or Unresectable or Metastatic Renal Cell Carcinoma (RCC)
Duke University
Phase NA Withdrawn
NCT05668949 2025-12-17
Phase I/II Open Label Study Evaluating the Safety and Efficacy of Combining STAT3 Inhibition (TTI-101) With Anti-PD-1 Therapy (Pembrolizumab) in Patients With Recurrent or Metastatic (RM) Head and Neck Squamous Cell Carcinoma (HNSCC)
M.D. Anderson Cancer Center
Phase 1/2 Withdrawn
NCT05845307 2025-12-08
Randomized Pre-surgical Window-of-Opportunity Trial of TTI-101 in Patients With Stage II-IV Resectable HPV-negative Squamous Cell Carcinoma of the Head and Neck
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Withdrawn
NCT06362421 2025-07-31
Saliva Testing for High-Risk Human Papillomavirus Infection Oral Cavity and Pharynx Cancer
Wake Forest University Health Sciences
Withdrawn
NCT06086925 2025-07-11
A Window of Opportunity Study of Black Raspberry for Patients With HNSCC
Milton S. Hershey Medical Center
Phase EARLY_PHASE1 Withdrawn
NCT04595981 2025-04-27
Chemo-embolization for Head and Neck Cancer
University of Alabama at Birmingham
Phase 2 Withdrawn
NCT05608369 2025-04-04
HPV
Case Comprehensive Cancer Center
Phase 2 Withdrawn
NCT05452408 2025-03-18
Antitumor-B KAC PK Study
Medical College of Wisconsin
Phase 1 Withdrawn
NCT06357858 2024-07-03
ASTX727 and Nivolumab in Squamous Cell Carcinoma of the Head and Neck
Case Comprehensive Cancer Center
Phase 1 Withdrawn
NCT05707702 2024-05-01
Lactobacillus Lozenges as Preventative Care in Low-grade Dysplasia
Boston Medical Center
Phase 3 Withdrawn
NCT05412875 2024-04-12
Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and Lung
Ohio State University Comprehensive Cancer Center
Phase NA Withdrawn
NCT04892875 2023-11-30
PANTHEoN
Vanderbilt-Ingram Cancer Center
Phase 1 Withdrawn
NCT03875053 2023-10-04
Home Sleep Apnea Machine in Evaluating Obstructive Sleep Apnea in Patients With Stage III-IV Head and Neck Cancer
Barbara Ann Karmanos Cancer Institute
Phase NA Withdrawn
NCT04834349 2023-09-13
Re-irradiation With NBTXR3 in Combination With Pembrolizumab for the Treatment of Inoperable Locoregional Recurrent Head and Neck Squamous Cell Cancer
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT04922112 2023-08-02
OSA-HN
University of Colorado, Denver
Phase NA Withdrawn
NCT04987996 2023-06-06
GR-MD-02 + Pembrolizumab Versus Pembrolizumab Monotherapy in Melanoma and Squamous Cell Head and Neck Cancer Patients
Providence Health & Services
Phase 2 Withdrawn
NCT01332279 2023-04-04
Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy
Fox Chase Cancer Center
Phase 1 Withdrawn
NCT04941365 2022-12-22
SERPENTINE
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Withdrawn
NCT04831450 2022-08-04
Phase 2 Trial of Maintenance Cemiplimab for Head and Neck Squamous Cell Carcinoma (HNSCC)
University of Miami
Phase 2 Withdrawn
NCT04849377 2022-07-07
RBD-HPV: Risk-Based De-Intensification for HPV+ HNSCC
Icahn School of Medicine at Mount Sinai
Phase 2 Withdrawn
NCT04003025 2022-04-20
HNCAX01
Instituto do Cancer do Estado de São Paulo
Withdrawn
NCT04266470 2022-03-29
Monitoring Blood Flow and Metabolic Activity in Malignant Tissue of Head and Neck Region
Wake Forest University Health Sciences
Phase NA Withdrawn
NCT05099952 2022-01-12
Sleep and Circadian Rhythm Study in Head and Neck Cancer Patients
Roswell Park Cancer Institute
Phase NA Withdrawn
NCT01967927 2021-08-19
Understanding GRID Radiation Therapy Effects on Human Tumor Oxygenation and Interstitial Pressure to Increase Translation of Solid Tumor Therapy
University of Arkansas
Phase EARLY_PHASE1 Withdrawn
NCT00492947 2021-04-30
Dendritic
University of Maryland, Baltimore
Phase 1 Withdrawn
NCT04262388 2020-11-17
DOME
University Health Network, Toronto
Phase 2 Withdrawn
NCT02686008 2020-01-13
Pharmacodynamic Study to Assess the Anti-proliferative Activity of the PARP Inhibitor Olaparib in Patients With HPV Positive and HPV Negative HNSCC
Yale University
Phase 1 Withdrawn
NCT03575234 2019-08-28
Nivolumab & IRX-2 With Surgery for Resectable Stage III-IVA Oral Cavity Cancer or HPV-Positive Oropharyngeal Cancer
Emory University
Phase 1 Withdrawn
NCT03611205 2019-08-07
Interim Digital PET/CT in Predicting Outcomes for Participants With Locally Advanced Oropharyngeal Cancer Undergoing Chemoradiation Therapy
Ohio State University Comprehensive Cancer Center
Phase NA Withdrawn
NCT03325465 2019-04-22
Neoadjuvant Pembrolizumab + Epacadostat Prior to Curative Surgical Care for Squamous Cell Carcinoma of the Head and Neck
University of Chicago
Phase 2 Withdrawn
NCT03114280 2019-04-08
PICH
Centre Antoine Lacassagne
Phase 1/2 Withdrawn
NCT02993991 2017-12-29
PRIMED-001
University Health Network, Toronto
Phase 1 Withdrawn
NCT02211027 2017-09-07
Biological Vaccine: Semi-allogeneic Human Fibroblasts (MRC-5) Transfected With DNA
University of Pittsburgh
Phase 1 Withdrawn
NCT01545687 2017-08-08
CD2 Lozenges in Preventing Acute Oral Mucositis in Patients With Head and Neck Cancer Receiving Radiotherapy and Chemotherapy
Alliance for Clinical Trials in Oncology
Phase 3 Withdrawn
NCT02593929 2017-06-08
Pharmacodynamic Effects and Predictive Biomarkers With Ruxolitinib in Operable Head and Neck Cancer
University of Pittsburgh
Phase EARLY_PHASE1 Withdrawn
NCT02649530 2016-09-30
A Phase II Trial Evaluating WNT974 in Patients With Metastatic Head and Neck Squamous Cell Carcinoma
University of Michigan Rogel Cancer Center
Phase 2 Withdrawn
NCT01820312 2016-08-08
A Phase II Study to Evaluate Low-Dose Fractionated Radiotherapy (LDFRT)
University of Arkansas
Phase 2 Withdrawn
NCT00041171 2016-07-12
Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery
Alliance for Clinical Trials in Oncology
Phase 3 Withdrawn
NCT02119728 2016-04-21
Photodynamic Therapy With HPPH in Treating Patients With Squamous Cell Carcinoma of the Oral Cavity
Roswell Park Cancer Institute
Phase 2 Withdrawn
NCT01586182 2015-09-04
Stereotactic Boost for Oropharyngeal Squamous Cell Carcinoma
Dana-Farber Cancer Institute
Phase 1/2 Withdrawn
NCT01133262 2015-03-10
Effectiveness in Head and Neck Cancer Detection Using Positron Emission Tomography (PET) Insert Device
Washington University School of Medicine
Withdrawn
NCT01718223 2014-09-03
Photodynamic Therapy Using Temoporfin Before Surgery in Treating Patients With Recurrent Oral Cavity or Oropharyngeal Cancer
Roswell Park Cancer Institute
Phase NA Withdrawn
NCT00616590 2014-06-17
Insomnia in Patients Undergoing Chemotherapy and Radiation Therapy for Head and Neck Cancer
Vanderbilt University
Withdrawn
NCT01728480 2013-12-11
Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy
Roswell Park Cancer Institute
Phase 1 Withdrawn
NCT01674374 2013-05-15
Botanical Therapy in Treating Mucositis in Patients With Head and Neck Cancer Who Have Undergone Chemoradiation Therapy
Roswell Park Cancer Institute
Phase 2 Withdrawn
NCT01427205 2013-04-05
Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC)
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT00038038 2012-08-01
Assessment of Head and Neck Tumor Hypoxia Using 18F-Fluoromisonidazole
M.D. Anderson Cancer Center
Phase NA Withdrawn